Search
for
Sort by
Research 181–210 of 1000+
- Recommendations on trichological treatments during COVID-19 pandemic
- Hydroxychloroquine, nitazoxanide and ivermectin have similar effects in early COVID-19: a head-to-head comparison of the Pre-AndroCoV Trial.
- Antiandrogens as Therapies for COVID-19: A Systematic Review
- Case Report: Rowell Syndrome–Like Flare of Cutaneous Lupus Erythematosus Following COVID-19 Infection
- Dermatologic Changes in Experimental Model of Long COVID
- Are sex hormones promising candidates to explain sex disparities in the COVID-19 pandemic?
- Early Antiandrogen Therapy With Dutasteride Reduces Viral Shedding, Inflammatory Responses, and Time-to-Remission in Males With COVID-19: A Randomized, Double-Blind, Placebo-Controlled Interventional Trial (EAT-DUTA AndroCoV Trial – Biochemical)
- Alert to US physicians: DHEA, widely used as an OTC androgen supplement, may exacerbate COVID-19
- Autoimmune Skin Diseases in the Era of COVID-19: Pathophysiological Insights and Clinical Implications
- Effect of COVID-19 on Hair Diseases Observed by Health Care Providers: Analysis of 513 participants
- O papel dos andrógenos na alopecia androgenética associada à gravidade do COVID-19
- Role of Endolysosomes in Severe Acute Respiratory Syndrome Coronavirus-2 Infection and Coronavirus Disease 2019 Pathogenesis: Implications for Potential Treatments
- Cutaneous manifestations of the COVID-19 pandemic in schoolchildren and adolescents
- A clinical case of a patient with mucocutaneous and musculoskeletal manifestations after COVID-19 vaccination
- Immunological aspects and gender bias during respiratory viral infections including novel Coronavirus disease‐19 (COVID‐19): A scoping review
- More than 50 long-term effects of COVID-19: a systematic review and meta-analysis
- Large Screening Identifies ACE2 Positively Correlates With NF-κB Signaling Activity and Targeting NF-κB Signaling Drugs Suppress ACE2 Levels
- Unraveling the mechanism of action of cepharanthine for the treatment of novel coronavirus pneumonia (COVID-19) from the perspectives of systematic pharmacology
- 5-alpha reductase inhibitors use in prostatic disease and beyond
- MAIT Cells in COVID-19: Heroes, Villains, or Both?
- The antiviral activity of a small molecule drug targeting the NSP1-ribosome complex against Omicron, especially in elderly patients
- The Impact of Angiotensin-Converting Enzyme 2 (ACE2) Expression Levels in Patients with Comorbidities on COVID-19 Severity: A Comprehensive Review
- Sex differences in COVID-19: the role of androgens in disease severity and progression
- Are sex discordant outcomes in COVID-19 related to sex hormones?
- Data-driven analysis to understand long COVID using electronic health records from the RECOVER initiative
- Proxalutamide Significantly Accelerates Viral Clearance and Reduces Time to Clinical Remission in Patients with Mild to Moderate COVID-19: Results from a Randomized, Double-Blinded, Placebo-Controlled Trial
- Use of Antiandrogens as Therapeutic Agents in COVID-19 Patients
- Coronavirus Infection and Cholesterol Metabolism
- The Silent Syndrome of Long COVID and Gaps in Scientific Knowledge: A Narrative Review
- Anticoronavirus Isoquinoline Alkaloids: Unraveling the Secrets of Their Structure–Activity Relationship